- $532.78m
- $411.06m
- $138.89m
- 67
- 26
- 20
- 31
Annual income statement for SI-Bone, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 67.3 | 73.4 | 90.2 | 106 | 139 |
| Cost of Revenue | |||||
| Gross Profit | 60.5 | 64.5 | 79.7 | 90.7 | 109 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 103 | 113 | 144 | 167 | 186 |
| Operating Profit | -36 | -40.1 | -53.5 | -60.3 | -46.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -38.4 | -43.7 | -56.6 | -61.3 | -43.3 |
| Net Income After Taxes | -38.4 | -43.7 | -56.6 | -61.3 | -43.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -38.4 | -43.7 | -56.6 | -61.3 | -43.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -38.4 | -43.7 | -56.6 | -61.3 | -43.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.55 | -1.45 | -1.65 | -1.77 | -1.13 |